Striatal Neurotransmitter Release-related Presynaptic Proteins in L-dopa Induced Dyskinesia in a Model of Parkinsonism

Por Çakmakli, Gül Yalçin, Vural, Atay, Koçak, Emine Eren, Elibol, Bülent, Saka, Esen
Publicado no Noro Psikiyatr Ars (2018)

Recrudescence of Deficits After Stroke: Clinical and Imaging Phenotype, Triggers, and Risk Factors

Por Topcuoglu, Mehmet A., Saka, Esen, Silverman, Scott B., Schwamm, Lee H., Singhal, Aneesh B.
Publicado no JAMA Neurol (2017)

Cognitive Dysfunction in Relation to Topography and Burden of Cerebral Microbleeds

Por Büyükşerbetçi, Gülseren, Saka, Esen, Oğuz, Kader Karli, Göçmen, Rahşan, Arsava, Ethem Murat, Topçuoğlu, Mehmet Akif
Publicado no Noro Psikiyatr Ars (2018)

Dysregulation of CalDAG-GEFI and CalDAG-GEFII predicts the severity of motor side-effects induced by anti-parkinsonian therapy

Por Crittenden, Jill R., Cantuti-Castelvetri, Ippolita, Saka, Esen, Keller-McGandy, Christine E., Hernandez, Ledia F., Kett, Lauren R., Young, Anne B., Standaert, David G., Graybiel, Ann M.
Publicado em 2009

Levodopa-Induced Dyskinesia Is Associated with Increased Thyrotropin Releasing Hormone in the Dorsal Striatum of Hemi-Parkinsonian Rats

Por Cantuti-Castelvetri, Ippolita, Hernandez, Ledia F., Keller-McGandy, Christine E., Kett, Lauren R., Landy, Alex, Hollingsworth, Zane R., Saka, Esen, Crittenden, Jill R., Nillni, Eduardo A., Young, Anne B., Standaert, David G., Graybiel, Ann M.
Publicado em 2010